Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines Subcommittee.

Oskoui M., Caller TA., Parsons J., Servais L., Butterfield RJ., Bharadwaj J., Rose SC., Tolchin B., Puskala Hamel K., Silsbee HM., Dowling JJ.

DOI

10.1212/WNL.0000000000214014

Type

Journal

Neurology

Publication Date

26/08/2025

Volume

105

Permalink Original publication